Research Articles
Engineering Hope: How Supercharged T-Cells Are Revolutionizing Myeloma Treatment
A groundbreaking therapy is teaching immune cells to hunt down one of medicine's most elusive cancers—with astonishing results.
The Secret Shuttles of Sweet Wormwood: Unlocking a Malaria Drug's Hidden Potential
Discover how ABCG transporters in Artemisia annua could revolutionize artemisinin production for malaria treatment.
From Chemotherapy to Biotechnology: The Transformation of Cancer Treatment at Roche
Explore Roche's transformation from traditional chemotherapy to innovative biotechnology in cancer treatment, featuring targeted therapies and monoclonal antibodies.
Heat Shock Protein 90: The Hidden Master Switch of Aggressive Breast Cancers
Discover how HSP90 amplification marks aggressive HER2-negative breast cancer phenotypes and its potential for diagnosis and treatment.
The Hidden Danger in the Heat: How Tiny Fibers Pose a Big Health Risk
Exploring the toxicological puzzle of Refractory Ceramic Fibers and their different health effects in rats and hamsters.
The Security Guards Within: How Tiny T Cells Protect Us From Ourselves
Explore the fascinating world of T cells and their role in immune regulation, including Nobel Prize-winning research on regulatory T cells.
The EGFR Balancing Act: How Scientists Are Outsmarting Cancer's Master Switch
Explore how scientists are exploiting both blockade and overstimulation of EGFR to develop powerful new cancer treatments, including groundbreaking experiments with multi-targeted antibodies.
Unlocking the Immune System: How Anti-PD-1 Antibodies Are Revolutionizing Cancer Treatment
Explore how anti-PD-1 antibodies are transforming cancer treatment by harnessing the body's immune system to fight tumors. Learn about mechanisms, combination therapies, and future directions.
The Hidden Universe Within: How Science Finally Read the Complete Human Genome
Discover how recent genomic breakthroughs have finally decoded the complete human genome, revealing secrets that promise to revolutionize medicine.
A New Key for the Body's Elite Soldiers: Supercharging an Obscure Immune Cell to Fight Childhood Leukemia
Discover how targeting BTN2A1 with a unique activating monoclonal antibody enhances Vγ9Vδ2 T cell cytotoxicity against primary acute lymphoblastic leukemia blasts.